Company / SG&A Expense
Steris SG&A Expense History
FY2016-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A Expense
$1.3B
FY2024
5-year range
$1.1B / $1.3B
FY2020-FY2024
Trend
+6.5%
vs FY2023
Sector context
#36 of 152
Health Care
What the data says
Steris's sg&a expense of $1.3B is higher than 76% of companies in the Health Care sector (FY2024). SG&A Expense has fluctuated over the past 8 years, ranging from $670M in FY2018 to $1.3B in FY2024.
Based on SEC 10-K filings.
$1.3B in FY2024 with a 5-year CAGR of +13.2%. Top quartile in the Health Care sector.
Increased from $1.1B to $1.3B over the past 2 years.
Health Care sector context is included.
SG&A Expense over time
Growth rates
- 3-Year CAGR
- +0.4%
- 5-Year CAGR
- +13.2%
- 10-Year CAGR
- -
Sector benchmark
Bottom 24% in Health CareTop 76% of 152This company $1.3B Sector average $182.7B
▼
-99.3% below sector average
Key checks
Key Insights
- 5-year CAGR of +13.2%, indicating consistent growth.
- In FY2024, sg&a expense increased 6.5% year-over-year.
- Ranks #36 out of 152 companies in the Health Care sector.
- Lowest sg&a expense in the period was in FY2018.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 1.06 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | $1.3B | +6.5% |
| FY2023 | $1.3B | +14.8% |
| FY2022 | $1.1B | -17.3% |
| FY2021 | $1.3B | +80.3% |
| FY2020 | $731.3M | +2.0% |
| FY2019 | $716.7M | +7.0% |
| FY2018 | $669.9M | - |
| FY2017 | - | - |
| FY2016 | $682.0M | - |
As of FY2024 · SEC 10-K · Updated Mar 13, 2026